Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRX-100 for Early to Moderate Presbyopia
NCT02554396Phase 2Completed
- Sponsor
- LENZ Therapeutics
- Start
- Sep 2015
- Primary completion
- Nov 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aceclidine, tropicamide in presbyopia, sponsored by LENZ Therapeutics. Started Sep 2015; status: completed.
02
Drugs
aceclidinetropicamide
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT02554396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02554396.